Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo
PTI, Mar 22, 2022, 9:14 AM IST
Image credit: Reuters
New Delhi: Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan’s Daiichi Sankyo Company to acquire the latter’s 11.28 percent stake in Zenotech Laboratories.
Sun Pharma said it will pay Rs 5.32 crore for the stake.
The primary objective of the transaction from the acquirer’s perspective is to consolidate its holding in the target company, the Mumbai-based drug firm said in a regulatory filing.
After the acquisition, Sun Pharma’s stake in Zenotech will increase from 57.56 percent to 68.84 percent, it added.
The acquisition is expected to complete in 30 days.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Choose correct ITR to report foreign assets; 2 lakh such returns filed: CBDT official
Air India Express increases flight operations from northeast destinations
Mcap of 8 of top-10 most-valued domestic firms jumps Rs 1.55 lakh cr; HDFC Bank, TCS sparkle
Myntra pilots foray into quick commerce with ‘M-Now’ in select locations of Bengaluru
Never entered into pact to operate airport in Kenya: Adani
MUST WATCH
Latest Additions
Karnataka HC rejects plea to quash FIR in Rs 69 lakh Amazon scam case
‘Wicked’ and ‘Gladiator’ make gravity-defying theatre debuts
Independent winner extends unconditional support to BJP
Those rejected by people trying to control Parliament: PM Modi
BMW hit-and-run case: HC refuses to release accused Mihir Shah on ground of ‘illegal’ arrest
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.